AVDL

Avadel Pharmaceuticals
AVDL

Overview Fund Trends Analyst Outlook Journalist POV

97 hedge funds and large institutions have $500M invested in Avadel Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 30 increasing their positions, 31 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less call options, than puts

Call options by funds: $ | Put options by funds: $

20% less capital invested

Capital invested by funds: $623M → $500M (-$122M)

25% less funds holding in top 10

Funds holding in top 10: 8 → 6 (-2)

Holders
97
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$907K
Puts
$1.01M
Net Calls
Net Calls Change

Top Buyers

1
+$12.9M
2
+$12.3M
3
+$9.91M
4
Deutsche Bank
Deutsche Bank
Germany
+$7.04M
5
JGC
J. Goldman & Co
New York
+$6.27M

Top Sellers

1
-$9.47M
2
-$6.39M
3
-$5.67M
4
KCM
Kennedy Capital Management
Missouri
-$4.93M
5
GTC
Ghost Tree Capital
New York
-$3.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$3.91M
27
$3.83M
28
$3.15M
29
$2.8M
30
$2.67M
31
$2.64M
32
$2.39M
33
$2.2M
34
$2.13M
35
$2.08M
36
$1.76M
37
$1.69M
38
$1.48M
39
$1.48M
40
$1.36M
41
$1.32M
42
$1.18M
43
$980K
44
$974K
45
$938K
46
$926K
47
$814K
48
$652K
49
$611K
50
$573K
1
2
3 4 5